Acadia Pharma Q1 2025 Earnings Preview

Posted on by wpadmin
  • Acadia Pharma (NASDAQ:ACAD) is scheduled to announce Q1 earnings results on Wednesday, May 7th, after market close.
  • The consensus EPS Estimate is $0.11 and the consensus Revenue Estimate is $238.97M (+16.1% Y/Y).
  • Over the last 3 months, EPS estimates have seen

Leave a Reply

Your email address will not be published. Required fields are marked *